Aggregation of human recombinant alpha-synuclein

Minee L Choi

Published: 2024-02-01 DOI: 10.17504/protocols.io.6qpvr35obvmk/v1

Abstract

This protocol describes a method of generating aggregation of human recombinant alpha-synuclein.

Steps

1.

Humanrecombinant α-Syn Monomeric WTα-Syn is purified from Escherichia coli as

previously described in

Citation
Hoyer W, Antony T, Cherny D, Heim G, Jovin TM, Subramaniam V 2002 Dependence of alpha-synuclein aggregate morphology on solution conditions. https://doi.org/
[Hoyer et al., 2002].

2.

Aggregation reactions are carried out using a solution of α-Syn 70micromolar (µM) in 25millimolar (mM) Tris buffervsupplemented with 100millimolar (mM) NaCl, 7.4 (in the presence of 0.01% volume % NaN3 to prevent bacterial growth).

3.

The buffer is freshly prepared before each experiment and passed through a 0.02 µm

syringe filter (Anotop, Whatman) to remove insoluble contaminants.

4.

Prior to incubation, the reaction mixture is ultra-centrifuged at 90k r.p.m. for 1h 0m 0s at 4°C to remove potential seeds.

5.

The supernatant is collected and separated in two fractions: one kept at 4°C at all

times until use(monomers), and a second incubated in the dark at 37°C37°C and200rpm,0h 0m 0s , during7h 0m 0s -8h 0m 0s hours to avoid fibril formation (monomers+oligomers).

6.

α-Syn is always kept in LoBind microcentrifuge tubes (Eppendorf, Hamburg, Germany) to

limit surface adsorption.

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询